» Articles » PMID: 28828001

Structure-activity Relationships and Molecular Docking Studies of Chromene and Chromene Based Azo Chromophores: A Novel Series of Potent Antimicrobial and Anticancer Agents

Overview
Journal EXCLI J
Specialty Biology
Date 2017 Aug 23
PMID 28828001
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The design of novel materials with significant biological properties is a main target in drug design research. Chromene compounds represent an interesting medicinal scaffold in drug replacement systems. This report illustrates a successful synthesis and characterization of two novel series of compounds using multi-component reactions. The synthesis of the first example of azo chromophores containing chromene moieties has also been established using the same methodology. The antimicrobial activity of the new molecules has been tested against seven human pathogens including two Gm+ve, two Gm-ve bacteria, and four fungi, and the results of the inhibition zones with minimum inhibitory concentrations were reported as compared to reference drugs. All the designed compounds showed significant potent antimicrobial activities, among of them, four potent compounds , , , and showed promising MIC from 0.007 to 3.9 µg/mL. In addition, antiproliferative analysis against three target cell lines was examined for the novel compounds. Compounds , , , and possessed significant antiproliferative activity against three cell lines with an IC of 0.3 to 2 µg/mL. Apoptotic analysis was performed for the most potent compounds via caspase enzyme activity assays as a potential mechanism for their antiproliferative effects. Finally, the computational 2D QSAR and docking simulations were accomplished for structure-activity relationship analyses.

Citing Articles

Regulation of adipocyte differentiation and lipid metabolism by novel synthetic chromenes exploring anti-obesity and broader therapeutic potential.

Inthanon K, Wong-A-Nan N, Dheeranupattana S, Guerra A, Davies N, Kesornpun C Sci Rep. 2025; 15(1):4051.

PMID: 39900791 PMC: 11790873. DOI: 10.1038/s41598-025-87945-1.


A supramolecular magnetic and multifunctional Titriplex V-grafted chitosan organocatalyst for the synthesis of acridine-1,8-diones and 2-amino-3-cyano-4-pyran derivatives.

Hassanzadeh N, Dekamin M, Valiey E Nanoscale Adv. 2024; .

PMID: 39502107 PMC: 11533062. DOI: 10.1039/d4na00264d.


Targeted potent antimicrobial and antitumor oxygen-heterocyclic-based pyran analogues: synthesis and computational studies.

El-Wahab A, Borik R, Al-Dies A, Fouda A, Mohamed H, El-Eisawy R Sci Rep. 2024; 14(1):9862.

PMID: 38684707 PMC: 11058275. DOI: 10.1038/s41598-024-59193-2.


Discovery of benzochromene derivatives first example with dual cytotoxic activity against the resistant cancer cell MCF-7/ADR and inhibitory effect of the -glycoprotein expression levels.

Al-Harbi L, Al-Harbi E, Okasha R, El-Eisawy R, El-Nassag M, Mohamed H J Enzyme Inhib Med Chem. 2023; 38(1):2155814.

PMID: 36662632 PMC: 9869995. DOI: 10.1080/14756366.2022.2155814.


Synthesis and Evaluation of Some New 4-Pyran Derivatives as Antioxidant, Antibacterial and Anti-HCT-116 Cells of CRC, with Molecular Docking, Antiproliferative, Apoptotic and ADME Investigations.

El-Sayed N, Zaki M, Al-Hussain S, Ben Bacha A, Berredjem M, Masand V Pharmaceuticals (Basel). 2022; 15(7).

PMID: 35890189 PMC: 9317316. DOI: 10.3390/ph15070891.


References
1.
Isakoff S . Triple-negative breast cancer: role of specific chemotherapy agents. Cancer J. 2010; 16(1):53-61. PMC: 2882502. DOI: 10.1097/PPO.0b013e3181d24ff7. View

2.
Kirilmis C, Ahmedzade M, Servi S, Koca M, Kizirgil A, Kazaz C . Synthesis and antimicrobial activity of some novel derivatives of benzofuran: part 2. The synthesis and antimicrobial activity of some novel 1-(1-benzofuran-2-yl)-2-mesitylethanone derivatives. Eur J Med Chem. 2007; 43(2):300-8. DOI: 10.1016/j.ejmech.2007.03.023. View

3.
Park J, Lee S, Kim S, Shin S, Lee J, Shin C . Chromone and chromanone derivatives as strand transfer inhibitors of HIV-1 integrase. Arch Pharm Res. 2008; 31(1):1-5. DOI: 10.1007/s12272-008-1111-z. View

4.
Berman H, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H . The Protein Data Bank. Nucleic Acids Res. 1999; 28(1):235-42. PMC: 102472. DOI: 10.1093/nar/28.1.235. View

5.
Stepanchikova A, Lagunin A, Filimonov D, Poroikov V . Prediction of biological activity spectra for substances: evaluation on the diverse sets of drug-like structures. Curr Med Chem. 2003; 10(3):225-33. DOI: 10.2174/0929867033368510. View